Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tenofovir DF in HIV-1 Infected Patients
NCT00007436Phase 3Unknown
- Sponsor
- Gilead Sciences
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Status: unknown.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00007436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007436.